GPC5 and neoplasm: Future studies should investigate whether GPC5-mutant LUAD patients exhibit altered tumor-infiltrating lymphocyte profiles and combine other in vivo and in vitro studies to explore the molecular mechanisms, thereby providing more in-depth therapeutic strategies.